Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-…
Biotechnology
US, Florham Park [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Phathom Pharmaceuticals, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPhathom Pharmaceuticals, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Phathom Pharmaceuticals, Inc..
If you want to see a demo, head over to the financial segments of AAPL